Transitional Care Interventions for Patients With Cirrhosis Post-TIPS

August 23, 2016 updated by: HOU Wei-wei, Shihezi University

Transitional Care Interventions Post-TIPS

The investigators conducted a randomized controlled trial to describe if multidisciplinary and patient-centered transitional care interventions for patients with cirrhosis post-TIPS can improve compliance behavior and reduce complications post-TIPS after discharge.

Study Overview

Status

Unknown

Conditions

Study Type

Interventional

Enrollment (Anticipated)

76

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Clinical diagnosis of diagnosis of cirrhosis;
  • Child-Pugh Score <10;
  • Informed Consent.

Exclusion Criteria:

  • Age <18 years;
  • Right ventricular failure;
  • Severe systemic infection;
  • Hepatocellular carcinoma (HCC);
  • Terminal disease; and
  • Failure to provide written consent to participate in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
The conventional care was performed for the patients of control group
Experimental: Intervention group
the prevention of complications post-TIPS
Continuous nursing through telephone follow-up, family visits, and WeChat guided patients to prevent gastrointestinal bleeding, infection and constipation ,intake quality low-protein diet, recognize minimal encephalopathy, monitor blood ammonia, return visit regularly, deal with adverse drug reactions of anticoagulant.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The compliance behavior associated with complications post-TIPS
Time Frame: 1 and 3 months after discharge
It was surveyed using a self-designed questionnaire based on evidence. The questionnaire includes 6 items that address taking medicine on time, quality low-protein diet intake, going to sleep at a regular time, moderate exercise, emotion regulation, regular follow-up. Item responses are on a 4-point scale (0 = never to 3 = always). Data were collected by face-to-face interviews with trained transition nurses. Change is being assessed
1 and 3 months after discharge

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
incidence of adverse events (shunt dysfunction and hepatic encephalopathy)
Time Frame: 1 and 3 months after discharge
Change is being assessed
1 and 3 months after discharge
Child-Pugh scores
Time Frame: Baseline, 1 and 3 months after discharge
Change is being assessed
Baseline, 1 and 3 months after discharge
Blood ammonia levels
Time Frame: Baseline, 1 and 3 months after discharge
Change is being assessed
Baseline, 1 and 3 months after discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (Actual)

September 1, 2015

Study Registration Dates

First Submitted

August 16, 2016

First Submitted That Met QC Criteria

August 23, 2016

First Posted (Estimate)

August 24, 2016

Study Record Updates

Last Update Posted (Estimate)

August 24, 2016

Last Update Submitted That Met QC Criteria

August 23, 2016

Last Verified

August 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • TCI-2016

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

According to the actual situation to decide whether to share data

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fibrosis

Clinical Trials on the prevention of complications post-TIPS

Subscribe